Clinical Trial: Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation

U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07370688) titled 'Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation' on Jan. 18.

Brief Summary: The aim of the open-label, randomized controlled superiority IRON TAVI trial is to investigate whether intravenous iron therapy (ferric carboxymaltose) improves Health-Related Quality of Life (HRQOL) in patients with severe aortic stenosis (AS) and iron deficiency (ID), undergoing transcatheter aortic valve implantation (TAVI).

The main questions it aims to answer are:

1. Does intravenous iron therapy improve HRQOL after TAVI in patients with severe AS and ID compared to no intravenous iron therapy (standard of care)?

2. Can i...